Patents by Inventor Jessica Baker Flechtner

Jessica Baker Flechtner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT METHODS
    Publication number: 20230057310
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for treating subjects having cancer, are provided herein.
    Type: Application
    Filed: September 27, 2019
    Publication date: February 23, 2023
    Inventors: Jessica Baker Flechtner, Marie Lossky-Elias, Pamela M. Carroll, Hubert Lam, Lisa K. McNeil, Wendy Jane Broom
  • TREATMENT METHODS
    Publication number: 20230041057
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for treating subjects having cancer, are provided herein.
    Type: Application
    Filed: September 27, 2019
    Publication date: February 9, 2023
    Inventors: Jessica Baker Flechtner, Marie Lossky-Elias, Pamela M. Carroll, Hubert Lam, Lisa K. McNeil, Wendy Jane Broom
  • TREATMENT METHODS
    Publication number: 20220412979
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein.
    Type: Application
    Filed: October 29, 2019
    Publication date: December 29, 2022
    Applicant: Genocea Biosciences, Inc.
    Inventors: Jessica Baker Flechtner, Jason R. Dobson
  • TREATMENT METHODS
    Publication number: 20220211832
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein. In some embodiments, the method comprises administering to the subject an immunogenic composition comprising one or more selected stimulatory antigens (e.g., one or more stimulatory antigens described herein) or immunogenic fragments thereof, wherein the immunogenic composition is administered according to a dosing regimen comprising an initial dose of the immunogenic composition and additional doses of the immunogenic composition, wherein after an initial dose is administered, an additional dose is administered 3 weeks following the initial dose, an additional dose is administered 6 weeks following the initial dose, an additional dose is administered 12 weeks following the initial dose, and an additional dose is administered 24 weeks following the initial dose.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 7, 2022
    Inventors: Jessica Baker Flechtner, Seth Vollmer Hetherington, Thomas Charles Heineman, Lisa K. McNeil
  • Antigen screening system
    Patent number: 11162093
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: November 2, 2021
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Baker Flechtner, Todd Gierahn
  • TREATMENT METHODS
    Publication number: 20210199644
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein.
    Type: Application
    Filed: October 30, 2020
    Publication date: July 1, 2021
    Inventors: Jessica Baker Flechtner, Marie Lossky-Elias, Pamela M. Carroll, Hubert Lam, Lisa K. McNeil, Wendy Jane Broom
  • ANTIGEN SCREENING SYSTEM
    Publication number: 20200385703
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Application
    Filed: January 16, 2020
    Publication date: December 10, 2020
    Inventors: Jessica Baker Flechtner, Todd Gierahn
  • Treatment methods
    Patent number: 10859566
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: December 8, 2020
    Assignee: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Baker Flechtner, Marie Lossky-Elias, Pamela M. Carroll, Hubert Lam, Lisa K. McNeil, Wendy Jane Broom
  • TREATMENT METHODS
    Publication number: 20190072543
    Abstract: Methods and compositions for identifying tumor antigens of human lymphocytes, and for identifying subjects for cancer therapy, are provided herein.
    Type: Application
    Filed: March 20, 2018
    Publication date: March 7, 2019
    Inventors: Jessica Baker Flechtner, Marie Lossky-Elias, Pamela M. Carroll, Hubert Lam, Lisa K. McNeil, Wendy Jane Broom
  • CHLAMYDIA ANTIGENS AND USES THEREOF
    Publication number: 20170043005
    Abstract: The present invention provides novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. The present invention further provides methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses). The present invention provides methods of prophylaxis and/or treatment of chlamydia-mediated diseases comprising administering an immunogenic composition including one or more of the novel antigens described herein.
    Type: Application
    Filed: March 24, 2016
    Publication date: February 16, 2017
    Inventors: Jessica Baker Flechtner, Kenya Prince Cohane, Todd Gierahn, Alexander Yao-Hsein Lee, George Rainer Siber
  • CHLAMYDIA ANTIGENS AND USES THEREOF
    Publication number: 20120135025
    Abstract: The present invention provides novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. The present invention further provides methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses). The present invention provides methods of prophylaxis and/or treatment of chlamydia-mediated diseases comprising administering an immunogenic composition including one or more of the novel antigens described herein.
    Type: Application
    Filed: October 20, 2011
    Publication date: May 31, 2012
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Baker Flechtner, Kenya Prince Cohane, Todd Gierahn, Alexander Yao-Hsien Lee, George Rainer Siber
  • Heat shock protein-based vaccines and immunotherapies
    Patent number: 7309491
    Abstract: Hybrid antigens comprising at least one antigenic domain, at least one heat shock protein binding domain, and at least one improved peptide linker there between are described which are useful for the induction of an immune response to the antigenic domain when administered alone or in a complex with at least one heat shock protein. The hybrid antigens and complexes can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: December 18, 2007
    Assignee: Antigenics Inc.
    Inventors: Paul Slusarewicz, Jessica Baker Flechtner, Sunil Mehta, Kenya Prince-Cohane, Sofija Andjelic, Brian H. Barber